Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 1—January 2019
CME ACTIVITY - Research

Prescription of Antibacterial Drugs for HIV-Exposed, Uninfected Infants, Malawi, 2004–2010

Alexander C. EwingComments to Author , Nicole L. Davis, Dumbani Kayira, Mina C. Hosseinipour, Charles van der Horst, Denise J. Jamieson, Athena P. Kourtis, and for the BreastfeedingAntiretrovirals and Nutrition study team
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (A.C. Ewing, N.L. Davis, D.J. Jamieson, A.P. Kourtis); University of North Carolina Project, Lilongwe, Malawi (D. Kayira); University of North Carolina, Chapel Hill, North Carolina, USA (M.C. Hosseinipour, C. van der Horst)

Main Article

Table 1

Antibacterial drugs used in the Breastfeeding, Antiretrovirals and Nutrition study, Malawi, 2004–2010

Class
 Drug
Aminoglycoside Gentamicin
Cephalosporins Ceftriaxone
Cefuroxime
Loracarbef
Nitroimidazole Metronidazole
Penicillins Amoxicillin
Ampicillin
Augmentin
Benzathine penicillin
Benzylpenicillin
Cloxacillin
Flucloxacillin
β-lactams/β-lactamase inhibitor combination
 Amoxicillin/clavulanate
Phenicols
 Chloramphenicol
Quinolones Ciprofloxacin
Nalidixic acid
Sulfonamides Cotrimoxazole
Sulfadiazine
Tetracyclines/macrolides Doxycycline
Erythromycin
Tetracycline

Main Article

1Team members are listed at the end of this article.

Page created: December 12, 2018
Page updated: December 12, 2018
Page reviewed: December 12, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external